GUIDED THERAPEUTICS INC Total Revenue

• GUIDED THERAPEUTICS INC showed an increase of +10,857.1% in Total Revenue from 2024 to 2025.
• This data is from GUIDED THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on March 31, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2014: $19.0 thousand | Q2 2014: $11.0 thousand | Q3 2014: $22.0 thousand | Q1 2015: $15.0 thousand | Q2 2015: $10.0 thousand | Q3 2015: $8.0 thousand | Q2 2017: $87.0 thousand | Q3 2017: $33.0 thousand | Q1 2018: $4.0 thousand | Q2 2018: $8.0 thousand | Q3 2018: $2.0 thousand | Q1 2019: $18.0 thousand | Q2 2019: $1.0 thousand | Q1 2020: $0.00 | Q2 2020: $0.00 | Q3 2020: $77.0 thousand | Q1 2021: $0.00 | Q2 2021: $2.0 thousand | Q3 2021: $19.0 thousand | Q1 2022: $5.0 thousand | Q2 2022: $5.0 thousand | Q3 2022: $3.0 thousand | Q1 2023: $22.0 thousand | Q2 2023: $44.0 thousand | Q3 2023: $0.00 | Q1 2024: $6.0 thousand | Q2 2024: $0.00 | Q3 2024: $0.00 | Q1 2025: $0.00 | Q2 2025: $117.0 thousand | Q3 2025: $60.0 thousand.
• Over the full 16 years of available data (2010 to 2025), GUIDED THERAPEUTICS INC's Total Revenue has declined by 77.2%.
• Historical annual values: Fiscal year 2025: $767.0 thousand | Fiscal year 2024: $7.0 thousand | Fiscal year 2023: $98.0 thousand | Fiscal year 2022: $13.0 thousand | Fiscal year 2021: $81.0 thousand | Fiscal year 2020: $102.0 thousand | Fiscal year 2019: $36.0 thousand | Fiscal year 2018: $57.0 thousand | Fiscal year 2017: $244.0 thousand | Fiscal year 2016: $0.00 | Fiscal year 2015: $42.0 thousand | Fiscal year 2014: $65.0 thousand | Fiscal year 2013: $820.0 thousand | Fiscal year 2012: $3.34 million | Fiscal year 2011: $3.60 million | Fiscal year 2010: $3.36 million.
• Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: August 7, 2026